NO315733B1 - Benzopyron-analoger, deres anvendelse og farmasöytiske preparater inneholdende dem - Google Patents

Benzopyron-analoger, deres anvendelse og farmasöytiske preparater inneholdende dem Download PDF

Info

Publication number
NO315733B1
NO315733B1 NO19952119A NO952119A NO315733B1 NO 315733 B1 NO315733 B1 NO 315733B1 NO 19952119 A NO19952119 A NO 19952119A NO 952119 A NO952119 A NO 952119A NO 315733 B1 NO315733 B1 NO 315733B1
Authority
NO
Norway
Prior art keywords
trans
dihydro
benzopyran
dimethyl
fluorobenzoylamino
Prior art date
Application number
NO19952119A
Other languages
English (en)
Norwegian (no)
Other versions
NO952119D0 (no
NO952119L (no
Inventor
John Morris Evans
Mervyn Thompson
Neil Upton
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO952119D0 publication Critical patent/NO952119D0/no
Publication of NO952119L publication Critical patent/NO952119L/no
Publication of NO315733B1 publication Critical patent/NO315733B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19952119A 1992-11-30 1995-05-29 Benzopyron-analoger, deres anvendelse og farmasöytiske preparater inneholdende dem NO315733B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1992/002222 WO1994012173A1 (en) 1992-11-30 1992-11-30 Benzopyron analogues for the treatment of anxiety, mania, depression or withdrawal symptoms

Publications (3)

Publication Number Publication Date
NO952119D0 NO952119D0 (no) 1995-05-29
NO952119L NO952119L (no) 1995-05-29
NO315733B1 true NO315733B1 (no) 2003-10-20

Family

ID=10709714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19952119A NO315733B1 (no) 1992-11-30 1995-05-29 Benzopyron-analoger, deres anvendelse og farmasöytiske preparater inneholdende dem

Country Status (5)

Country Link
CZ (1) CZ282172B6 (cs)
FI (1) FI952609L (cs)
NO (1) NO315733B1 (cs)
SK (1) SK281507B6 (cs)
WO (1) WO1994012173A1 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
US6298535B1 (en) 2000-02-16 2001-10-09 William Ross Lower Wheel lifting rod assembly
DE10348298A1 (de) * 2003-10-17 2005-05-19 Solvay Pharmaceuticals Gmbh Amidomethyl-substituierte 2-(4-Sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP1836183A2 (en) 2004-12-13 2007-09-26 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479726D1 (de) * 1983-05-18 1989-10-19 Beecham Group Plc Benzopyran derivatives.
US4632939A (en) * 1985-03-15 1986-12-30 Eli Lilly And Company Anticonvulsant agents
DE3679378D1 (de) * 1985-09-03 1991-06-27 Ciba Geigy Ag 3-amino-dihydro-(1)-benzopyrane und benzothiopyrane.
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use

Also Published As

Publication number Publication date
SK281507B6 (sk) 2001-04-09
CZ282172B6 (cs) 1997-05-14
NO952119D0 (no) 1995-05-29
CZ139095A3 (en) 1996-01-17
FI952609A7 (fi) 1995-05-30
SK70995A3 (en) 1995-11-08
NO952119L (no) 1995-05-29
FI952609L (fi) 1995-05-30
WO1994012173A1 (en) 1994-06-09
FI952609A0 (fi) 1995-05-29

Similar Documents

Publication Publication Date Title
KR100287969B1 (ko) 불안감소 및 항-경련 활성을 갖는 벤조-및 피리도피란 유도체
DE69315920T2 (de) Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung
DD284678A5 (de) Verfahren zur herstellung von neuen cyclischen aminderivaten
WO2007010383A1 (ja) 新規なヘテロシクリデンアセトアミド誘導体
US5006570A (en) Dihydrobenzofuran- and chroman-carboxamide derivatives, processes for the preparation thereof and use thereof as neuroleptics
SK283837B6 (sk) Chrómany, spôsob ich prípravy, liečivá, ktoré ich obsahujú, a ich použitie
CA3101226A1 (en) P-phenylenediamine derivative as potassium channel regulator and preparation method and medical application thereof
KR20110027798A (ko) 6-치환 페녹시크로만 카르복실릭 애시드 유도체
US5861394A (en) Use of N-substituted phenothiazines
NO315733B1 (no) Benzopyron-analoger, deres anvendelse og farmasöytiske preparater inneholdende dem
KR20160147278A (ko) 새로운 유형의 kcnq 칼륨 통로 작동제, 그의 제조 방법 및 그의 용도
EP0673248A1 (en) Potassium channel activators for use in therapy
SK131898A3 (en) Chromans substituted by sulfonamide group, their preparation, their use as medicaments or diagnostics, as well as pharmaceutical compositions containing same
EA012414B1 (ru) Гетероарилсульфоны и сульфонамиды и их терапевтические применения
US5624954A (en) Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
US6015822A (en) Sulfonamide-substituted fused 5-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them
SK284859B6 (sk) Benzopyránové deriváty substituované sulfónamidovou skupinou, spôsob ich prípravy, ich použitie ako liečiv a farmaceutické prostriedky, ktoré ich obsahujú
DE60019619T2 (de) Dihydrobenzofuranderivate, verfahren zu ihrer herstellung und mittel
AP360A (en) Benzo-and pyridopyran derivatives having anxiolytic and anticonvulsant activity.
EA003606B1 (ru) 1,5-ПЕНТАНДИИЛЗАМЕЩЕННЫЕ 1,2,3,4-ТЕТРАГИДРОБЕНЗО (ФУРО, АЗО И ТИО) [3,2-c] ПИРИДИНОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ α-АНТАГОНИСТОВ
HK1019004B (en) Benzo- and pyridopyran derivatives having anxiolytic and anti-convulsant activity
HK1039613A (en) Trans-6-acetyl-4s-(4-fluorobenzoylamino)-3,4-dihydro-2,2-dimethyl-2h-1-benzopyran-3r-ol
AU5908599A (en) Substituted dihydrobenzopyrans useful as antiarrhythmic agents
SI9200378A (en) Benzopyran derivates and heterocyclic analogs thereof as pharmacologically active agents
US20020072514A1 (en) Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical preparations comprising them